Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Flovent manufacturer?Opdualag manufacturer?Which companies manufacture the drug betaseron?Is sapropterin's neuro benefit predictable by specific biomarkers?Which companies manufacture the drug aubagio?
See the DrugPatentWatch profile for Mexiletine
Mexiletine is classified as an oral antiarrhythmic medicine in the sodium-channel blocker family (Class IB), used to treat certain abnormal heart rhythms. [1]
Mexiletine is prescribed for ventricular arrhythmias, particularly when there is a need for suppression of abnormal electrical activity in the ventricles. [1]
As a Class IB antiarrhythmic, mexiletine works by blocking cardiac sodium channels. This slows sodium-dependent electrical conduction and changes repolarization behavior in a way that helps reduce certain arrhythmias. [1]
In clinical practice, mexiletine is commonly discussed alongside other antiarrhythmic sodium-channel–acting options, but it specifically falls under Class IB (as opposed to other antiarrhythmic classes that block different ion channels or have different electrophysiologic effects). [1]
You can cross-check mexiletine’s drug information, including its approval and market context, on DrugPatentWatch.com: [2] Sources: [1] https://www.drugs.com/mexiletine.html [2] https://www.drugpatentwatch.com/
Other Questions About Mexiletine :